Global Breakthrough Therapy Drugs Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 17017

Breakthrough therapy drugs are intended to treat serious and life-threatening conditions. The breakthrough therapy is the designation given by FDA for the drugs when there is a preliminary clinical evidence indicates that the drug proves a substantial improvement over available drug treatment. Two factors determine the efficiency of breakthrough therapy drug, they are the magnitude of the treatment effect and observed clinical difference over the existed drug.  The standard for breakthrough therapy drug is not same as standard drug approval because, in breakthrough therapy, morbidity and mortality considered for approval of the drug. They are meant to be administered by itself or in combinations. Breakthrough therapy drug development is cost effective due to faster approval of drugs on limited data from the FDA. Manufacturer of breakthrough therapy drugs has to develop additional post-marketing surveillance data for the other reimbursements and market access. Presently available breakthrough therapy medicinal products in the market belong to the treatment class of oncology, infectious diseases, cardiovascular conditions, etc. The designation is given when the drug is in 1st or 2nd stage of clinical trials.
Increasing prevalence of life-threatening conditions and for the speedy development of pipeline drugs is the primary driver for the breakthrough therapy drugs market. This is because of the high unmet need of presently available treatment for severe conditions. Breakthrough designation of the drug captures the more attention of the manufacturers due to the expedited market access and greater returns on their investments. Because of Breakthrough therapy drugs market are associated with less robust clinical developments. Increasing support of FDA for small scale industries in R&D by providing additional funding and faster approval of drugs fuelling the growth of the breakthrough therapy drugs market. All these factors are boosting the growth of the breakthrough therapy drug market.
Breakthrough therapy designation requires additional planning for the pricing, market access and reimbursements acts as restraints in the growth of the market. Uncertainty around the breakthrough therapy drugs acts as a primary challenge for the manufacturers.

The global Breakthrough Therapy Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Breakthrough Therapy Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Breakthrough Therapy Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Merck
Pfizer
AbbVie
Bristol-Myers Squibb Company
Genentech
Gilead
Novartis
Vertex Pharmaceuticals Incorporated

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Oncology
Anti-Viral
Neurology
Others 

Segment by Application
Hospitals
Clinics
Ambulatory Services

Table of Contents

Executive Summary
1 Breakthrough Therapy Drugs Market Overview
1.1 Product Overview and Scope of Breakthrough Therapy Drugs
1.2 Breakthrough Therapy Drugs Segment by Type
1.2.1 Global Breakthrough Therapy Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Oncology
1.2.3 Anti-Viral
1.2.4 Neurology
1.2.5 Others 
1.3 Breakthrough Therapy Drugs Segment by Application
1.3.1 Breakthrough Therapy Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Services
1.4 Global Breakthrough Therapy Drugs Market by Region
1.4.1 Global Breakthrough Therapy Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Breakthrough Therapy Drugs Market Size
1.5.1 Global Breakthrough Therapy Drugs Revenue (2014-2025)
1.5.2 Global Breakthrough Therapy Drugs Production (2014-2025)

2 Global Breakthrough Therapy Drugs Market Competition by Manufacturers
2.1 Global Breakthrough Therapy Drugs Production Market Share by Manufacturers (2014-2019)
2.2 Global Breakthrough Therapy Drugs Revenue Share by Manufacturers (2014-2019)
2.3 Global Breakthrough Therapy Drugs Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Breakthrough Therapy Drugs Production Sites, Area Served, Product Types
2.5 Breakthrough Therapy Drugs Market Competitive Situation and Trends
2.5.1 Breakthrough Therapy Drugs Market Concentration Rate
2.5.2 Breakthrough Therapy Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Breakthrough Therapy Drugs Production Market Share by Regions
3.1 Global Breakthrough Therapy Drugs Production Market Share by Regions
3.2 Global Breakthrough Therapy Drugs Revenue Market Share by Regions (2014-2019)
3.3 Global Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Breakthrough Therapy Drugs Production
3.4.1 North America Breakthrough Therapy Drugs Production Growth Rate (2014-2019)
3.4.2 North America Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Breakthrough Therapy Drugs Production
3.5.1 Europe Breakthrough Therapy Drugs Production Growth Rate (2014-2019)
3.5.2 Europe Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Breakthrough Therapy Drugs Production (2014-2019)
3.6.1 China Breakthrough Therapy Drugs Production Growth Rate (2014-2019)
3.6.2 China Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Breakthrough Therapy Drugs Production (2014-2019)
3.7.1 Japan Breakthrough Therapy Drugs Production Growth Rate (2014-2019)
3.7.2 Japan Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Breakthrough Therapy Drugs Consumption by Regions
4.1 Global Breakthrough Therapy Drugs Consumption by Regions
4.2 North America Breakthrough Therapy Drugs Consumption (2014-2019)
4.3 Europe Breakthrough Therapy Drugs Consumption (2014-2019)
4.4 China Breakthrough Therapy Drugs Consumption (2014-2019)
4.5 Japan Breakthrough Therapy Drugs Consumption (2014-2019)

5 Global Breakthrough Therapy Drugs Production, Revenue, Price Trend by Type
5.1 Global Breakthrough Therapy Drugs Production Market Share by Type (2014-2019)
5.2 Global Breakthrough Therapy Drugs Revenue Market Share by Type (2014-2019)
5.3 Global Breakthrough Therapy Drugs Price by Type (2014-2019)
5.4 Global Breakthrough Therapy Drugs Production Growth by Type (2014-2019)

6 Global Breakthrough Therapy Drugs Market Analysis by Applications
6.1 Global Breakthrough Therapy Drugs Consumption Market Share by Application (2014-2019)
6.2 Global Breakthrough Therapy Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Breakthrough Therapy Drugs Business
7.1 Merck
7.1.1 Merck Breakthrough Therapy Drugs Production Sites and Area Served
7.1.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.1.3 Merck Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pfizer
7.2.1 Pfizer Breakthrough Therapy Drugs Production Sites and Area Served
7.2.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.2.3 Pfizer Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 AbbVie
7.3.1 AbbVie Breakthrough Therapy Drugs Production Sites and Area Served
7.3.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.3.3 AbbVie Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Bristol-Myers Squibb Company
7.4.1 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Production Sites and Area Served
7.4.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.4.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Genentech
7.5.1 Genentech Breakthrough Therapy Drugs Production Sites and Area Served
7.5.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.5.3 Genentech Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Gilead
7.6.1 Gilead Breakthrough Therapy Drugs Production Sites and Area Served
7.6.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.6.3 Gilead Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Novartis
7.7.1 Novartis Breakthrough Therapy Drugs Production Sites and Area Served
7.7.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.7.3 Novartis Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Vertex Pharmaceuticals Incorporated
7.8.1 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Production Sites and Area Served
7.8.2 Breakthrough Therapy Drugs Product Introduction, Application and Specification
7.8.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Breakthrough Therapy Drugs Manufacturing Cost Analysis
8.1 Breakthrough Therapy Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Breakthrough Therapy Drugs
8.4 Breakthrough Therapy Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Breakthrough Therapy Drugs Distributors List
9.3 Breakthrough Therapy Drugs Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Breakthrough Therapy Drugs Market Forecast
11.1 Global Breakthrough Therapy Drugs Production, Revenue Forecast
11.1.1 Global Breakthrough Therapy Drugs Production Growth Rate Forecast (2019-2025)
11.1.2 Global Breakthrough Therapy Drugs Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Breakthrough Therapy Drugs Price and Trend Forecast (2019-2025)
11.2 Global Breakthrough Therapy Drugs Production Forecast by Regions (2019-2025)
11.2.1 North America Breakthrough Therapy Drugs Production, Revenue Forecast (2019-2025)
11.2.2 Europe Breakthrough Therapy Drugs Production, Revenue Forecast (2019-2025)
11.2.3 China Breakthrough Therapy Drugs Production, Revenue Forecast (2019-2025)
11.2.4 Japan Breakthrough Therapy Drugs Production, Revenue Forecast (2019-2025)
11.3 Global Breakthrough Therapy Drugs Consumption Forecast by Regions (2019-2025)
11.3.1 North America Breakthrough Therapy Drugs Consumption Forecast (2019-2025)
11.3.2 Europe Breakthrough Therapy Drugs Consumption Forecast (2019-2025)
11.3.3 China Breakthrough Therapy Drugs Consumption Forecast (2019-2025)
11.3.4 Japan Breakthrough Therapy Drugs Consumption Forecast (2019-2025)
11.4 Global Breakthrough Therapy Drugs Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Breakthrough Therapy Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer